{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:06:58Z","timestamp":1786975618788,"version":"build-2736575974"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.15934","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T11:00:58Z","timestamp":1654599658000},"page":"e2215934","source":"Crossref","is-referenced-by-count":77,"title":["Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States"],"prefix":"10.1001","volume":"5","author":[{"given":"Sally B.","family":"Coburn","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Humes","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raynell","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Medicine, University of Calgary, Calgary, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenna C.","family":"Hogan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Gebo","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Napravnik","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill"},{"name":"Department of Epidemiology, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie K.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay E.","family":"Browne","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley S.","family":"Park","sequence":"additional","affiliation":[{"name":"Stanford Center for Population Health Sciences, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Justice","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut"},{"name":"Department of Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"VA Connecticut Healthcare System, West Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsha S.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"VA Connecticut Healthcare System, West Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Horberg","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Mid-Atlantic States, Mid-Atlantic Permanente Research Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Certa","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Mid-Atlantic States, Mid-Atlantic Permanente Research Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Watson","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Mid-Atlantic States, Mid-Atlantic Permanente Research Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeena R.","family":"Jefferson","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Mid-Atlantic States, Mid-Atlantic Permanente Research Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Silverberg","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Skarbinski","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"},{"name":"Department of Infectious Diseases, Oakland Medical Center, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Leyden","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn F.","family":"Williams","sequence":"additional","affiliation":[{"name":"Epidemiology Branch, Division of AIDS at National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri N.","family":"Althoff","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Corona-Infectious-Virus Epidemiology Team (CIVETs) of the NA-ACCORD of IeDEA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"issue":"27","key":"zoi220466r1","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine.","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi220466r2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"zoi220466r3","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19.","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"issue":"21","key":"zoi220466r4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.15585\/mmwr.mm7021e3","article-title":"COVID-19 vaccine breakthrough infections reported to CDC\u2014United States, January 1-April 30, 2021.","volume":"70","author":"Birhane","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"zoi220466r5","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1111\/ajt.v21.6","article-title":"Postvaccination SARS-CoV-2 infections among skilled nursing facility residents and staff members\u2014Chicago, Illinois, December 2020-March 2021.","volume":"21","author":"Teran","year":"2021","journal-title":"Am J Transplant"},{"key":"zoi220466r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101117","article-title":"Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population.","volume":"40","author":"Butt","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"23","key":"zoi220466r7","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1056\/NEJMoa2105000","article-title":"Vaccine breakthrough infections with SARS-CoV-2 variants.","volume":"384","author":"Hacisuleyman","year":"2021","journal-title":"N Engl J Med"},{"issue":"13","key":"zoi220466r8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.15585\/mmwr.mm7013e3","article-title":"Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers\u2014eight U.S. locations, December 2020-March 2021.","volume":"70","author":"Thompson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"24","key":"zoi220466r9","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1001\/jama.2021.6564","article-title":"Asymptomatic and symptomatic SARS-CoV-2 infections after BNT162b2 vaccination in a routinely screened workforce.","volume":"325","author":"Tang","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"zoi220466r11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jinf.2021.05.021","article-title":"Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination.","volume":"83","author":"Butt","year":"2021","journal-title":"J Infect"},{"issue":"2","key":"zoi220466r12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jamainternmed.2021.7024","article-title":"Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US.","volume":"182","author":"Sun","year":"2022","journal-title":"JAMA Intern Med"},{"key":"zoi220466r14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/med.2011.62.issue-1","article-title":"HIV infection, inflammation, immunosenescence, and aging.","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"issue":"2","key":"zoi220466r15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/ije\/dyl286","article-title":"Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).","volume":"36","author":"Gange","year":"2007","journal-title":"Int J Epidemiol"},{"issue":"8","key":"zoi220466r17","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/01.mlr.0000223670.00890.74","article-title":"Development and verification of a \u201cvirtual\u201d cohort using the National VA Health Information System.","volume":"44","author":"Fultz","year":"2006","journal-title":"Med Care"},{"issue":"8","key":"zoi220466r19","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1111\/ajt.v21.8","article-title":"Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients.","volume":"21","author":"Malinis","year":"2021","journal-title":"Am J Transplant"},{"issue":"10","key":"zoi220466r20","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1097\/TP.0000000000003902","article-title":"Breakthrough COVID-19 infections after mRNA vaccination in solid organ transplant recipients in Miami, Florida.","volume":"105","author":"Anjan","year":"2021","journal-title":"Transplantation"},{"key":"zoi220466r21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ejca.2021.10.014","article-title":"Immunogenicity and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection after coronavirus disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.","volume":"160","author":"Becerril-Gaitan","year":"2022","journal-title":"Eur J Cancer"},{"issue":"August","key":"zoi220466r22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab687","article-title":"Effectiveness of SARS-CoV-2 mRNA vaccines for preventing COVID-19 hospitalizations in the United States.","author":"Tenforde","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"6578","key":"zoi220466r23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.abm0620","article-title":"SARS-CoV-2 vaccine protection and deaths among US veterans during 2021.","volume":"375","author":"Cohn","year":"2022","journal-title":"Science"},{"issue":"1","key":"zoi220466r24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/wps.v21.1","article-title":"Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021.","volume":"21","author":"Wang","year":"2022","journal-title":"World Psychiatry"},{"issue":"12","key":"zoi220466r25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243523","article-title":"Behavioral measures to fight COVID-19: an 8-country study of perceived usefulness, adherence and their predictors.","volume":"15","author":"Margraf","year":"2020","journal-title":"PLoS One"},{"issue":"7-8","key":"zoi220466r26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/08982643211002084","article-title":"Risk perception, preventive behavior, and medical care avoidance among American older adults during the COVID-19 pandemic.","volume":"33","author":"Lu","year":"2021","journal-title":"J Aging Health"},{"issue":"11","key":"zoi220466r28","doi-asserted-by":"publisher","first-page":"e690","DOI":"10.1016\/S2352-3018(21)00239-3","article-title":"Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data.","volume":"8","author":"Yang","year":"2021","journal-title":"Lancet HIV"},{"issue":"2","key":"zoi220466r29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37069","article-title":"COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State.","volume":"4","author":"Tesoriero","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi220466r30","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/ccr3.v9.3","article-title":"COVID-19: prolonged viral shedding in an HIV patient with literature review of risk factors for prolonged viral shedding and its implications for isolation strategies.","volume":"9","author":"Yousaf","year":"2021","journal-title":"Clin Case Rep"},{"key":"zoi220466r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104577","article-title":"Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19.","volume":"130","author":"Corsini Campioli","year":"2020","journal-title":"J Clin Virol"},{"issue":"1","key":"zoi220466r32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/jmv.v93.1","article-title":"Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.","volume":"93","author":"Li","year":"2021","journal-title":"J Med Virol"},{"key":"zoi220466r10","doi-asserted-by":"crossref","unstructured":"Liu? C, Lee? J, Ta? C, . A retrospective analysis of COVID-19 mRNA vaccine breakthrough infections\u2014risk factors and vaccine effectiveness.? medRxiv. Preprint posted online October 7, 2021. doi:10.1101\/2021.10.05.21264583","DOI":"10.1101\/2021.10.05.21264583"},{"key":"zoi220466r13","unstructured":"Centers for Disease Control and Prevention. COVID-19 vaccines for moderately to severely immunocompromised people. Accessed October 28, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/immuno.html"},{"key":"zoi220466r16","unstructured":"Centers for Disease Control and Prevention. When you\u2019ve been fully vaccinated. Accessed November 4, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/fully-vaccinated.html"},{"key":"zoi220466r18","unstructured":"Centers for Disease Control and Prevention. AIDS-defining conditions: MMWR recommendations and reports. Published December 5, 2008. Accessed November 17, 2021. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5710a2.htm"},{"key":"zoi220466r27","unstructured":"CDC COVID Data Tracker. COVID-19 weekly cases and deaths per 100,000 population by age, race\/ethnicity, and sex. Accessed November 6, 2021. https:\/\/covid.cdc.gov\/covid-data-tracker\/#demographicsovertime"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2793102\/coburn_2022_oi_220466_1654005895.56216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T11:01:01Z","timestamp":1654599661000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2793102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.15934","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.02.21267182","asserted-by":"object"}]},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]}}}